Discover your unique microbiome profile with advanced testing

Learn More →
Bile Acid Metabolites

Deoxycholic Acid (DCA)

Deoxycholic acid is the most abundant secondary bile acid in humans, with antimicrobial properties but also potential links to colorectal cancer when chronically elevated.

Context-dependent
Bile Acids Colorectal Cancer Antimicrobial Fat Digestion
#1
Most abundant secondary bile acid
DCA
Deoxycholic acid abbreviation
C. diff
Inhibits this pathogen

Health Effect: Context-dependent

The health effects of this metabolite depend on levels and individual circumstances.

Production Pathway

Precursors
Cholic acid (primary bile acid)Dietary fat
Bacteria
ClostridiumClostridium
Metabolite
Deoxycholic Acid (DCA)

Producing Bacteria

Clostridium scindens View details →
Clostridium hiranonis View details →
Clostridium hylemonae View details →
Eubacterium species

Affected Body Systems

This metabolite influences the following body systems:

Digestive Immune Hepatic

Deoxycholic acid (DCA) is the predominant secondary bile acid in humans, produced when gut bacteria transform the primary bile acid cholic acid through a process called 7α-dehydroxylation. This metabolite exemplifies the complexity of microbiome-derived compounds—providing important protective functions while also posing risks when chronically elevated [^bernstein2005].

Formation and Metabolism

Production Pathway

  1. Liver synthesizes cholic acid from cholesterol
  2. Cholic acid is conjugated and secreted in bile
  3. Most is reabsorbed in the small intestine
  4. ~5% reaches the colon
  5. Specific bacteria remove the 7α-hydroxyl group
  6. Deoxycholic acid is formed
  7. DCA is reabsorbed and recirculated

Key Producing Bacteria

Only a limited number of bacterial species can perform 7α-dehydroxylation:

  • Clostridium scindens: The best-studied DCA producer
  • Clostridium hiranonis: Important in bile acid metabolism
  • Clostridium hylemonae: Contributes to the bile acid pool

The restricted nature of this metabolic capability means DCA production can vary significantly based on microbiome composition.

Protective Functions

Antimicrobial Activity

DCA has potent antimicrobial properties, particularly against:

Clostridioides difficile

Research has shown that secondary bile acids, including DCA, inhibit C. difficile growth and spore germination. This explains why:

  • Antibiotic use (which depletes bile acid-producing bacteria) increases C. diff risk
  • Fecal microbiota transplant restores protection partly through bile acid normalization [^buffie2015]

Other Pathogens

DCA's detergent-like properties disrupt membranes of various bacteria, helping maintain a healthy microbiome composition.

Fat Absorption

Like all bile acids, DCA participates in fat digestion and absorption of fat-soluble vitamins (A, D, E, K).

Potential Health Concerns

Colorectal Cancer Association

Epidemiological and experimental evidence links elevated DCA to colorectal cancer risk [^bernstein2005]:

Mechanisms of Potential Harm

  1. DNA damage: DCA can cause oxidative DNA damage
  2. Apoptosis resistance: Chronic exposure may select for apoptosis-resistant cells
  3. Inflammation: High DCA levels promote inflammatory signaling
  4. Cell proliferation: May stimulate abnormal cell growth
  5. Membrane damage: Detergent properties can harm the gut lining

Risk Factors for High DCA

  • High-fat diets (more cholic acid substrate)
  • Low-fiber diets (reduced dilution, longer transit time)
  • High red meat consumption
  • Obesity
  • Certain microbiome compositions

The Western Diet Connection

The "Western diet" (high fat, low fiber) is associated with:

  • Increased bile acid secretion
  • Higher colonic DCA concentrations
  • Greater colorectal cancer risk

This may partly explain geographic variations in colorectal cancer rates.

Balancing DCA Levels

Dietary Strategies

To Reduce Excessive DCA

  1. Increase fiber intake: Dilutes bile acids, speeds transit
  2. Reduce saturated fat: Less bile acid secretion needed
  3. Eat more plant foods: Associated with lower DCA levels
  4. Include calcium: May bind bile acids in the colon

Foods That May Help

  • Whole grains
  • Legumes
  • Fruits and vegetables
  • Fermented dairy (calcium source)

Lifestyle Factors

  • Maintain healthy weight
  • Regular physical activity
  • Avoid smoking

Clinical Applications

Cosmetic Use

Interestingly, synthetic DCA (brand name Kybella) is FDA-approved for reducing submental fat ("double chin"). When injected, DCA's membrane-disrupting properties destroy fat cells.

Research Areas

  • DCA as a biomarker for colorectal cancer risk
  • Targeting bile acid metabolism for cancer prevention
  • Understanding DCA's role in microbiome-immune interactions

Testing DCA Levels

Available Tests

  • Stool bile acid analysis
  • Serum bile acid panels
  • Comprehensive digestive stool analysis (CDSA)

Interpretation Considerations

  • Levels vary with recent diet
  • Should be interpreted alongside other bile acids
  • Ratio of primary to secondary bile acids may be informative
  • Context of overall gut health matters

When to Consider Testing

  • Strong family history of colorectal cancer
  • Symptoms of bile acid malabsorption
  • After antibiotic treatment with digestive changes
  • Recurrent C. difficile infections

DCA in Perspective

While DCA has concerning associations, it's important to maintain perspective:

  1. DCA is natural: Everyone with a functioning gut microbiome produces DCA
  2. Dose matters: Problems arise from chronic elevation, not normal levels
  3. Diet is key: Lifestyle factors largely determine DCA exposure
  4. Balance is goal: Neither too high nor too low is ideal

The goal isn't to eliminate DCA but to maintain healthy levels through diet and lifestyle choices that support overall gut health.

Dietary Precursors

These dietary factors influence production:

Cholic acid (primary bile acid) Dietary fat

How to Test Your Levels

Available testing methods for Deoxycholic Acid (DCA):

  • Stool bile acid analysis
  • Serum bile acid panel
  • Specialized metabolomics
Explore testing options

References

  1. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H.. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47-65. doi:10.1016/j.mrrev.2004.08.001
  2. Buffie CG, Bucci V, Stein RR, et al.. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205-208. doi:10.1038/nature13828